TFCP
AGN

Twin Focus Capital Partners’s Allergan plc AGN Stock Holding History

Twin Focus Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,316
Closed -$303K – 97
2016
Q3 		$303K Buy
+1,316
New +$322K 0.21% 56
2016
Q1 		– Sell
-649
Closed -$203K – 96
2015
Q4 		$203K Buy
+649
New +$193K 0.2% 80

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Twin Focus Capital Partners's AGN Position: Q4 2016 in Review

Twin Focus Capital Partners sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 1,316 shares — an estimated $303K sold.

Twin Focus Capital Partners first reported a position in AGN in Q4 2015 and held it in 2 quarters. The position peaked at $303K in Q3 2016. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Twin Focus Capital Partners reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Twin Focus Capital Partners sold 1,316 Allergan plc shares in Q4 2016, an estimated $303K.
  • Twin Focus Capital Partners first reported a position in Allergan plc in Q4 2015 and held it in 2 quarters.
  • Twin Focus Capital Partners's Allergan plc position peaked at $303K in Q3 2016.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Twin Focus Capital Partners's 13F filing for Q4 2016, filed 10 Feb 2017.